FALZONI, Simonetta
 Distribuzione geografica
Continente #
NA - Nord America 8.309
AS - Asia 4.006
EU - Europa 3.186
SA - Sud America 633
AF - Africa 51
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.198
Nazione #
US - Stati Uniti d'America 8.161
SG - Singapore 1.679
CN - Cina 1.217
DE - Germania 1.031
BR - Brasile 538
IT - Italia 481
UA - Ucraina 389
HK - Hong Kong 370
FI - Finlandia 319
TR - Turchia 247
GB - Regno Unito 242
RU - Federazione Russa 222
VN - Vietnam 220
PL - Polonia 182
SE - Svezia 107
CA - Canada 68
ID - Indonesia 66
MX - Messico 63
IN - India 52
FR - Francia 49
AR - Argentina 38
NL - Olanda 32
BD - Bangladesh 30
LT - Lituania 30
JP - Giappone 26
ZA - Sudafrica 26
BE - Belgio 20
IQ - Iraq 20
ES - Italia 18
EC - Ecuador 16
AT - Austria 13
IE - Irlanda 11
IL - Israele 11
CZ - Repubblica Ceca 10
IR - Iran 10
PY - Paraguay 10
AU - Australia 9
PK - Pakistan 9
VE - Venezuela 9
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
PE - Perù 7
CH - Svizzera 6
KE - Kenya 6
EG - Egitto 5
PA - Panama 5
RO - Romania 5
SA - Arabia Saudita 5
CL - Cile 4
KR - Corea 4
MA - Marocco 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
LV - Lettonia 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
MY - Malesia 2
NG - Nigeria 2
OM - Oman 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EU - Europa 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
JM - Giamaica 1
KZ - Kazakistan 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 16.198
Città #
Singapore 933
Ashburn 871
Fairfield 801
Woodbridge 781
Houston 492
Chandler 483
Santa Clara 466
Jacksonville 432
Beijing 420
Munich 387
Hong Kong 368
Ann Arbor 353
Seattle 300
Wilmington 273
Ferrara 250
Cambridge 248
Dallas 188
Warsaw 166
Helsinki 162
Izmir 142
Los Angeles 141
Nanjing 133
New York 127
Princeton 112
Addison 106
San Diego 83
Boardman 78
Shanghai 77
Ho Chi Minh City 65
Turku 54
Jakarta 53
São Paulo 49
Buffalo 47
Mexico City 43
Hanoi 42
Milan 39
Nanchang 39
Chicago 38
London 38
Dong Ket 37
Shenyang 37
Moscow 34
Bremen 32
Dearborn 32
Hebei 30
Hefei 29
Brooklyn 28
The Dalles 27
Changsha 24
Chennai 24
Frankfurt am Main 24
Tianjin 24
Jiaxing 23
Nuremberg 23
Atlanta 22
Montreal 22
San Francisco 22
Toronto 22
Denver 21
Stockholm 21
Boston 20
Columbus 20
Jinan 19
Brussels 18
Tokyo 18
Norwalk 17
Johannesburg 16
Orem 16
Phoenix 16
Falkenstein 14
Jyväskylä 14
Manchester 14
Ningbo 14
San Mateo 14
Brasília 13
Amsterdam 12
Bologna 12
Curitiba 12
Da Nang 12
Mountain View 12
Redwood City 12
Rio de Janeiro 12
Falls Church 11
Poplar 11
Salvador 11
Zhengzhou 11
Ankara 10
Auburn Hills 10
Augusta 10
Baghdad 10
Council Bluffs 10
Guangzhou 9
Mumbai 9
Ravenna 9
Taizhou 9
Washington 9
Biên Hòa 8
Charlotte 8
Des Moines 8
Haiphong 8
Totale 10.936
Nome #
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 367
A new luciferase target to the extracellular surface of the plasma membrane reveals a new pathway for ATP release in live intact cells. 334
Characterization of P2X7 isoform B sheds light on the role of pore versus channel activity in P2X7 mediated life and death. 317
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7 268
P2X7 targeting inhibits growth of human mesothelioma 254
A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion 252
1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: Correlation with histological variants and clinical parameters 244
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 237
Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells 233
Amyloid beta-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine 227
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment 225
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 222
ATP-mediated cytotoxicity in microglial cells 213
P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration 198
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 193
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination 188
The antibiotic polymyxin B modulates P2X7 receptor function 187
Plasma P2X7 receptor correlation with plasma C-reactive protein in infectious diseases 187
ATP secreted by endothelial cells blocks CX 3CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y 11 receptor activation 186
The P2X7 receptor is a key modulator of aerobic glycolysis. 185
ATP receptors and giant cell formation 184
Purinoceptor function in the immune system 183
The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein 182
A new method for measuring local ATP release at the extracellular surface of live intact cells 179
Non-nucleotide agonists triggering P2X7 receptor activation and pore formation 179
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 174
Blockade of P2X7 receptor inhibits formation of multinucleated giant cells. 173
Dysfunctional inflammasome in Schnitzler's syndrome 172
The P2X7 Receptor in Infection and Inflammation 171
P2 receptors in cancer progression and metastatic spreading 167
The P2X7 receptor-interleukin-1 liaison 163
Altered IL-1ß secretion in a patient affected by Schnitzler's syndrome 161
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4 161
Expression of the P2X7 receptor and metabolic adaptation in serum and glucose deprivation 160
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 159
The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility 157
CYTOLYTIC P2X PURINOCEPTORS 157
The P2 purinergic receptors of human dendritic cells: Identification and coupling to cytokine release 156
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib 156
Stable expression in HEK293 cells and characterization of P2X7 isoform B: new hints on P2X7 mediated cell survival. 153
High glucose modulates P2X7 receptor-mediated function in human primary fibroblasts 153
Trophic activity of a naturally occuring isoform of the P2X7 receptor 151
Association of Hypomorphic P2X7 Receptor Genotype With Age 150
ATP in the tumour microenvironment drives expression of nfP2X(7), a key mediator of cancer cell survival 150
Role of the purinergic P2Z receptor in spontaneous cell death in j774 macrophage cultures 147
Altered IL-1 beta secretion in a patient affected by Schintzler's syndrome 146
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance 146
P2X7 receptor has a key role in multinucleated giant cells formation. 146
Cellular biosensors for the identification of fetal hemoglobin inducers 144
P2X7 receptor and polykarion formation 143
The P2X7 receptor and pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF 143
Use of luciferase probes to measure ATP in living cells and animals 143
The P2X7-inflammasome connection: a novel pathway in autoinflammatory diseases. 142
P2 purinoceptors in the immune system 142
Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells 138
The Purinergic P2Z Receptor of Human Macrophage Cells: Characterization and Possible Physiological Role 136
Association of 1513CC P2X7 receptor genotype with age 135
Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor 134
Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance 134
The P2X7 receptor for extracellular nucleotides: a novel player in bone remodelling 133
The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism 132
Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7 131
Extarcellular ATP triggers IL-1beta release by activating the purinergic P2Z receptor of human macrophages 130
CHIMERIC PROTEINS FOR MEASURING ATP CONCENTRATIONS IN PERICELLULAR SPACE AND RELATED SCREENING METHOD 130
Detecting adenosine triphosphate in the pericellular space 129
Expression of the P2X7 receptor add metabolic adaptation in serum and glucose deprivation 128
Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth 128
Purinergic signaling in giant cell formation 128
The P2Z/P2X7 receptor of microglial cells: A novel immunomodulatory receptor 128
Pharmacological blockade of the P2X7 receptor reverses retinal damage in a rat model of type 1 diabetes 127
P2X7: a novel growth-stimulating receptor in B lymphoblastoid cells 124
Activation of microglia by amyloid  requires P2X7 receptor expression 124
Effects of extracellular ATPand adenosine on osteoclast development 123
Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation 121
Nucleotide receptor: an emerging family of regulatory molecules in blood cells 117
P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors 116
Expression and function of the P2X7 receptor in human osteoblasts: The role of NFATc1 transcription factor 114
Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin 108
Signalling by extracellular nucleotides in health and disease 107
In-vivo measurement of the extracellular ATP concentration by bio-luminescence: The pmeLUC probe 106
Mouse dendritic cells express the P2X7 purinergic receptor: Characterization and possible participation in antigen presentation 106
Islet-Derived eATP Fuels Autoreactive CD8+ Cells and Facilitates the Onset of Type 1 Diabetes 106
Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra 104
The purinergic P2Z receptor is expressed by human macrophages and upregulated by gamma interferon 100
Human P2X7 isoform B: a trophic receptor 98
Immunological evidence of an early seroconversion to oncogenic Merkel cell polyomavirus in healthy children and young adults 97
Extracellular ATP causes ROCK I-dependent bleb formation in P2X(7)-transfected HEK293 cells 97
SCHNITZLER AND SAPHO SYNDROMES: A MOLECULAR LINK BETWEEN P2X7 RECEPTOR AND INFLAMMASOME COMPLEX 96
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells 95
null 94
Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X(7) receptor 94
Modulation of Cell Energy Metabolism by the P2X7 Receptor 93
P2Z purinergic receptor expression correlates with spontaneous cell death of J774 macrophages in vitro 92
Blocking P2X7 by intracerebroventricular injection of P2X7-specific nanobodies reduces stroke lesions 90
Assessing Extracellular ATP as Danger Signal In Vivo: The pmeLuc System 89
Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. 86
Fetal bovine serum contains biologically available ATP 85
The purinergic P2Z receptor is expressed by human macrophages and up-regulated by gamma interferon 85
null 84
null 84
Totale 15.246
Categoria #
all - tutte 77.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.066
Totale 80.421


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021945 0 0 0 0 0 175 46 159 59 207 199 100
2021/20221.136 25 123 56 37 40 35 80 51 29 84 111 465
2022/20231.090 119 66 35 133 183 141 39 127 146 10 65 26
2023/2024711 76 86 33 15 86 108 37 60 16 8 29 157
2024/20253.273 67 78 205 143 335 409 207 214 584 297 385 349
2025/20264.028 876 290 604 925 1.202 131 0 0 0 0 0 0
Totale 16.418